D. Hallengärd

发表

Kinetic and Phenotypic Analysis of CD8+ T Cell Responses after Priming with Alphavirus Replicons and Homologous or Heterologous Booster Immunizations

K. Ljungberg, P. Liljeström, M. Esteban, 2014, Journal of Virology.

Heterologous Booster Immunizations Alphavirus Replicons and Homologous or Cell Responses after Priming with T + Kinetic and Phenotypic Analysis of CD 8

K. Ljungberg, P. Liljeström, M. Esteban, 2014 .

Oral delivery of transgenic plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to higher doses

A. Bråve, D. Hallengärd, Å. Strid, 2012, Retrovirology.

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation

E. Sandström, B. Wahrén, P. Blomberg, 2010, Vaccine.

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.

B. Wahrén, A. Bråve, R. Stout, 2009, Vaccine.

Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice

P. Roques, P. Liljeström, J. Fazakerley, 2013, Journal of Virology.

Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma

K. Pietras, S. Catrina, M. Hellström, 2010, Oncogene.

Attenuated and vectored vaccines protect nonhuman primates against Chikungunya virus.

P. Roques, N. Tchitchek, K. Ljungberg, 2017, JCI insight.

A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection

C. Sorzano, P. Liljeström, M. Esteban, 2014, Journal of Virology.

InfectionMice against Chikungunya MVA-CHIKV, Is Highly Immunogenic and A Novel Poxvirus-Based Vaccine,

M. Esteban, V. Cepeda, S. Sorzano, 2014 .

Strategies to enhance the potency of HIV-1 DNA vaccines

D. Hallengärd, 2011 .

Improving the immunogenicity of HIV-1 DNA vaccines.

D. Hallengärd, 2010 .

Prime-Boost Immunization Strategies against Chikungunya Virus

L. Ng, P. Roques, P. Liljeström, 2014, Journal of Virology.

Increased expression and immunogenicity of HIV-1 protease following inactivation of the enzymatic activity.

B. Wahrén, M. Isaguliants, A. Bråve, 2011, Vaccine.

Micro-minicircle Gene Therapy: Implications of Size on Fermentation, Complexation, Shearing Resistance, and Expression

K. E. Lundin, M. Rutland, B. Wahrén, 2014, Molecular therapy. Nucleic acids.

Therapeutics and vaccines against chikungunya virus.

T. Ahola, P. Roques, A. Powers, 2015, Vector borne and zoonotic diseases.

Induction of HIV-1-specific cellular and humoral immune responses following immunization with HIV-DNA adjuvanted with activated apoptotic lymphocytes.

U. Johansson, B. Wahrén, A. Spetz, 2010, Vaccine.

Broad and potent cellular and humoral immune responses after a second late HIV-modified vaccinia virus ankara vaccination in HIV-DNA-primed and HIV-modified vaccinia virus Ankara-boosted Swedish vaccinees.

P. Earl, M. Robb, V. Polonis, 2014, AIDS research and human retroviruses.

Immunization with multiple vaccine modalities induce strong HIV-specific cellular and humoral immune responses.

P. Earl, B. Moss, B. Wahrén, 2012, Viral immunology.

A truncated plasmid-encoded HIV-1 reverse transcriptase displays strong immunogenicity.

B. Wahrén, A. Bråve, D. Hallengärd, 2013, Viral immunology.

Cellular Immunogenicity of Novel Gene Immunogens in Mice Monitored by in Vivo Imaging

M. Isaguliants, Y. Kuzmenko, O. Krotova, 2012, Molecular imaging.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011

R. Shattock, B. Wahrén, G. Scarlatti, 2012, Journal of Translational Medicine.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010

P. Palma, M. V. van Gils, Sarah Brinckmann, 2010, Journal of Translational Medicine.

Intranasal immunization of young mice with a multigene HIV-1 vaccine in combination with the N3 adjuvant induces mucosal and systemic immune responses.

B. Wahrén, P. Blomberg, A. Bråve, 2008, Vaccine.

HIVIS-DNA or HIVISopt-DNA priming followed by CMDR vaccinia-based boosts induce both humoral and cellular murine immune responses to HIV

B. Moss, M. Robb, M. Eller, 2017, Heliyon.

Oral delivery of plant-derived HIV-1 p24 antigen in low doses shows a superior priming effect in mice compared to high doses.

Sören Andersson, Åke Strid, Ingrid Lindh, 2014, Vaccine.

A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines

B. Wahrén, P. Blomberg, M. Isaguliants, 2012, Genetic vaccines and therapy.

Correction: Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

P. Palma, P. Selhorst, M. V. van Gils, 2010, Journal of Translational Medicine.

Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference

P. Palma, P. Selhorst, M. V. van Gils, 2010, Journal of Translational Medicine.

Consensus HIV-1 FSU-A Integrase Gene Variants Electroporated into Mice Induce Polyfunctional Antigen-Specific CD4+ and CD8+ T Cells

M. Gottikh, M. Isaguliants, S. Petkov, 2013, PloS one.

Comparison of Plasmid Vaccine Immunization Schedules Using Intradermal In Vivo Electroporation

B. Wahrén, A. Bråve, D. Hallengärd, 2011, Clinical and Vaccine Immunology.

CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization

T. Lehner, E. Sandström, B. Wahrén, 2012, Retrovirology.

Combining DNA technologies and different modes of immunization for induction of humoral and cellular anti-HIV-1 immune responses.

A. Bråve, V. Blazevic, I. Stanescu, 2009, Vaccine.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011

R. Shattock, G. Scarlatti, F. Fiorino, 2012, Journal of Translational Medicine.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010

M. V. van Gils, D. Hallengärd, L. Mainetti, 2010, Journal of Translational Medicine.

A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection

C. Sorzano, P. Liljeström, M. Esteban, 2014, Journal of Virology.

Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice

P. Roques, P. Liljeström, J. Fazakerley, 2013, Journal of Virology.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010

M. V. van Gils, D. Hallengärd, L. Mainetti, 2010, Journal of Translational Medicine.